Ipsen S.A./€IPN

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Ipsen S.A.

Ipsen S.A. is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. The company focuses on the development and commercialization of innovative medicines in targeted therapeutic areas such as oncology, neuroscience, and rare diseases. Ipsen's key products include Somatuline, a treatment for neuroendocrine tumors and acromegaly, and Dysport, used for movement disorders and aesthetic indications. Founded in 1929 by Henri Beaufour, Ipsen has since expanded its presence worldwide, with a strategic emphasis on specialty care and the development of differentiated products. The company leverages its scientific expertise and research capabilities to sustain its competitive position in the biopharmaceutical industry.

Ticker

€IPN

Primary listing

PAR

Employees

5,358

Ipsen S.A. Metrics

BasicAdvanced
€8.8B
19.77
€5.37
0.19
€1.40
1.32%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €IPN

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs